NCT00510302View on ClinicalTrials.gov

Melanoma Risk-Reduction Among Patients and Family Members

CompletedOBSERVATIONAL
Enrollment

170

Participants

Timeline

Start Date

November 18, 2002

Primary Completion Date

September 14, 2020

Study Completion Date

September 14, 2020

Conditions
Melanoma
Interventions
BEHAVIORAL

Questionnaire

Questionnaire regarding melanoma risk-reduction.

BEHAVIORAL

Interview

Interview via telephone about topics related to melanoma risk-reduction.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT00510302 - Melanoma Risk-Reduction Among Patients and Family Members | Biotech Hunter | Biotech Hunter